Form 4: Insider Buys 200,000 Shares of Neuronetics

Director Jorey Chernett acquired 200,000 shares of Neuronetics, Inc. common stock through multiple transactions on April 20-21, 2026.

Summary

• Jorey Chernett, a Director at Neuronetics, Inc., purchased a total of 200,000 shares of common stock.
• The purchases occurred on April 20, 2026, for 100,000 shares at a weighted average price of $1.58, and on April 21, 2026, for 100,000 shares at a weighted average price of $1.51.
• Following these transactions, Chernett beneficially owns 9,978,988 shares of common stock, all held directly.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive signal due to significant insider buying by a director, indicating confidence in the company's value and future prospects.

Positives

• Significant insider buying activity by a Director, indicating confidence in the company's future prospects.
• Acquisition of 200,000 shares demonstrates a substantial personal investment in Neuronetics, Inc.

Future Outlook

No specific forward-looking statements or guidance are present in this Form 4 filing, which solely reports on past transactions.

Industry Context

StockSavvy.ai notes that insider buying, particularly by directors, is often interpreted by the market as a positive signal of management's belief in the company's intrinsic value and future growth potential. This activity in the medical technology sector, specifically for Neuronetics, Inc. (STIM), could be viewed in the context of the company's ongoing efforts to commercialize its neurostimulation devices.

Stakeholder Impact

• Shareholders may view this insider purchase positively, potentially leading to increased confidence and a favorable market reaction.
• The company's management team, including the reporting person, is demonstrating a vested interest in the company's performance.

Key Dates

Recommendation

While insider buying is a positive indicator, a Form 4 filing solely reports past transactions and does not provide new fundamental information about the company's performance or future outlook. Therefore, a 'hold' recommendation is appropriate, suggesting investors maintain their current positions while awaiting further company updates or financial reports.

Keywords

Neuronetics, STIM, Form 4, Insider Trading, Stock Purchase, Director Transaction, Beneficial Ownership